Open House Pharmaceutical Discounts On The Active Ingredient Omalizumab, Atc R03Dx05

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 104924771

  Document Type - Tender Notices

Description - Description: Completion of non-exclusive discount contracts in accordance with Sections 130a (8/13) SGB V for medicinal products with the above-mentioned active ingredient within the period from 01.05.2025 to 30.04.2027 with at any time to conclude t he contract (open house model). In the open house process, medicines are excluded according to the BfArM list according to § 35 Paragraph 5a SGB V (children's medicine).local title:: Open house Arzneimittelrabattverträge zum Wirkstoff Omalizumab, ATC R03DX05Contract Type: : Supplylocal description: : Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes

Gt Ref Id - 104924771

Deadline - Feb 28, 2027